CTNNA3 (alpha-catenin) gene variants are associated with diisocyanate asthma: a replication study in a Caucasian worker population
-
2013/01/01
-
Details
-
Personal Author:Bernstein DI ; Boulet L-P ; Cartier A ; Cruz M-J ; Fluharty K ; Gautrin D ; Germolec D ; Johnson VJ ; Kashon M ; Lummus ZL ; Luster MI ; Malo J-L ; Munoz X ; Quirce S ; Sastre J ; Tarlo SM ; Yucesoy, Berran
-
Description:Recently, a genome-wide association study (GWAS) conducted in Korean subjects identified four CTNNA3 (alpha-T catenin) single nucleotide polymorphisms (SNPs) (rs10762058, rs7088181, rs1786929, and rs4378283) associated with diisocyanate-induced occupational asthma (DA). The CTNNA3 gene codes for a cadherin involved in formation of stretch-resistant cell-cell adhesions. We conducted a candidate gene association study to replicate these findings in Caucasian workers. Genotyping was performed on DNA using a 5L nuclease PCR assay collected from 410 diisocyanate exposed and predominantly Canadian workers including 132 workers with DA confirmed by a specific inhalation challenge (DA+); 131 symptomatic workers in whom DA was excluded by a negative challenge (DA.); and 147 hexamethylene diisocyanate exposed asymptomatic workers (AWs). As in the Korean study, highly linked CTNNA3 rs7088181 and rs10762058 SNPs (but not rs4378283 and rs1786929) were significantly associated with DA+ when compared with AWs but not in comparison with DA. workers (p . 0.05). After adjusting for potentially confounding variables of age, smoking status, and duration of exposure, minor allele homozygotes of rs7088181 and rs10762058 SNPs were at increased risk for DA compared with AWs (OR = 9.05 [95% CI: 1.69, 48.54] and OR = 6.82 [95% CI: 1.65, 28.24], respectively). In conclusion, we replicated results from the only reported GWAS study of DA demonstrating an association between two closely linked CTNNA3 gene SNPs and DA. These findings lend further support to the clinical relevance of these genotypes in predicting susceptibility to DA and the potential importance of catenins in the disease process. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:1096-6080
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Pages in Document:242-246
-
Volume:131
-
Issue:2
-
NIOSHTIC Number:nn:20042179
-
Citation:Toxicol Sci 2013 Jan; 131(1):242-246
-
Contact Point Address:David I. Bernstein, Division of Immunology, Allergy and Rheumatology, University of Cincinnati Department of Internal Medicine, 3255 Eden Avenue, Suite 350, Cincinnati, OH 45267-0563
-
Email:bernstdd@ucmail.uc.edu
-
CAS Registry Number:
-
Federal Fiscal Year:2013
-
NORA Priority Area:
-
Performing Organization:University of Cincinnati
-
Peer Reviewed:True
-
Start Date:20060901
-
Source Full Name:Toxicological Sciences
-
End Date:20180831
-
Collection(s):
-
Main Document Checksum:urn:sha-512:e6c08996ab1a49fc2bf08575900c04cd33bcfeda925b182dab963be47aa25e751c54782777f0ea6ac3c4d2d6814739e336e60b870a9df7375b950764eb9a5201
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like